Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
PaperCitations, authors & open-access status
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 284 citations, 2017 year and hybrid oa status.
284
Citations
2017
Year
hybrid
OA Status